INDIRECT COST IN NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW

被引：0
|
作者：
Schmidt, E. [1 ]
Stanisic, S. [1 ]
Neumann, M. [1 ]
Walzer, S. [2 ]
机构：
[1] Analyt Int Inc, Lorrach, Germany
[2] F Hoffmann La Roche Pharmaceut AG, Basel, Switzerland
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A271 / A271
页数：1
相关论文
共 50 条
  • [1] The cost of non-small cell lung cancer (NSCLC) treatment
    Vergnenegre, A.
    ONCOLOGIE, 2012, 14 (05) : 310 - 315
  • [2] A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
    Ansgar Lange
    Anne Prenzler
    Martin Frank
    Heiko Golpon
    Tobias Welte
    J-Matthias von der Schulenburg
    BMC Pulmonary Medicine, 14
  • [3] A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)
    Lange, Ansgar
    Prenzler, Anne
    Frank, Martin
    Golpon, Heiko
    Welte, Tobias
    von der Schulenburg, J-Matthias
    BMC PULMONARY MEDICINE, 2014, 14
  • [4] SYSTEMATIC LITERATURE REVIEW OF TREATMENTS FOR PATIENTS WITH UNTREATED ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC)
    Song, J.
    Huang, M.
    Kelkar, S. S.
    Zhou, Z.
    Zhang, Y.
    VALUE IN HEALTH, 2018, 21 : S15 - S16
  • [5] SYSTEMIC TREATMENTS IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC REVIEW
    Harrison, James P.
    Goncalves, Teresa
    Kim, Hansoo
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 158 - 158
  • [6] Staging of non-small cell lung cancer (NSCLC): A review
    Tsim, S.
    O'Dowd, C. A.
    Milroy, R.
    Davidson, S.
    RESPIRATORY MEDICINE, 2010, 104 (12) : 1767 - 1774
  • [7] Is there an oligometastatic state in non-small cell lung cancer? A systematic review of the literature
    Ashworth, Allison
    Rodrigues, George
    Boldt, Gabriel
    Palma, David
    LUNG CANCER, 2013, 82 (02) : 197 - 203
  • [8] Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC)
    Jovanoski, Nick
    Abogunrin, Seye
    Di Maio, Danilo
    Belleli, Rossella
    Hudson, Pollyanna
    Bhadti, Sneha
    Jones, Libby G. G.
    PHARMACOECONOMICS, 2023, 41 (11) : 1437 - 1452
  • [9] Systematic Literature Review to Identify Cost and Resource Use Data in Patients with Early-Stage Non-small Cell Lung Cancer (NSCLC)
    Nick Jovanoski
    Seye Abogunrin
    Danilo Di Maio
    Rossella Belleli
    Pollyanna Hudson
    Sneha Bhadti
    Libby G. Jones
    PharmacoEconomics, 2023, 41 : 1437 - 1452
  • [10] Hybrid PET/MRI in non-small cell lung cancer (NSCLC) and lung nodules—a literature review
    Sara E. Dahlsgaard-Wallenius
    Malene Grubbe Hildebrandt
    Allan Johansen
    Mie Holm Vilstrup
    Henrik Petersen
    Oke Gerke
    Poul Flemming Høilund-Carlsen
    Anni Morsing
    Thomas Lund Andersen
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 584 - 591
12345